secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001213900-25-056188
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive Therapeutics effects 1-for-10 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-10 ratio effective June 18, 2025; begins trading split-adjusted June 20, 2025.
- Reduces outstanding shares from ~126.4M to ~12.6M; no fractional shares (rounded up).
- CUSIP changes to 90466Y 202; symbol remains UNCY.
- Board authorized reverse split on June 9, 2025; split intended to meet $1.00 minimum bid price for Nasdaq listing.
- Proportional adjustments to stock options, warrants, and preferred stock conversion prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025056188/0001213900-25-056188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025056188/ea0246299-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-056188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer